Search Results

Open Orphan branches out amid infectious disease gold rush

Open Orphan branches out amid infectious disease gold rush

Malaria has plagued humankind since our very evolution. It infects hundreds of millions of people every year and kills hundreds of thousands. Now, with the Covid-19 pandemic still raging on, the mosquito-borne illness is on our minds more than ever. Critically, with...

Open Orphan targets 2021 profits as spin-off seeks London listing

Open Orphan targets 2021 profits as spin-off seeks London listing

Open Orphan (LON: ORPH) on Thursday announced not only strong annual results but also that spin-off Poolbeg is planning to seek admission to trading on London’s AIM market. The company explained that Poolbeg will primarily use the funds raised as part of its admission...

Open Orphan to spin off non-core assets and focus on challenge studies

Open Orphan to spin off non-core assets and focus on challenge studies

Open Orphan (LON: ORPH) is planning to spin off its non-core assets and direct energy towards its fast-growing hVIVO challenge studies unit, which just won a £3 million contract. The separation will maximise value for shareholders while taking advantage of a challenge...

Open Orphan and hVIVO’s human vaccine trial for Covid-19 begins

Open Orphan and hVIVO’s human vaccine trial for Covid-19 begins

The first volunteer has been dosed with a COVID-19 vaccine as part of hVIVO’s phase 1 clinical trial of COVI-VAC. Following on from its announcement in July last year, the CRO, part of Open Orphan (LSE: ORPH), has begun its randomised, double-blinded,...

Live Indices

Live commodities

Live FX Rates